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Abstract 
Fahr syndrome which presents with various signs and symptoms has a familial predisposition and is characterized 
by symmetric calcification of basal ganglia. It may present with neuropsychiatric, extrapyramidal, and cerebellar 
symptoms. The etiology has not been defined yet. A 38-year-old woman referred to the psychiatric clinic of 5th Azar 
Hospital, Gorgan, Iran, with neuropsychiatric presentation. 
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Introduction1 
Fahr’s syndrome is idiopathic calcification of the 
basal ganglia.1 Clinical features are important since 
basal ganglia calcification may be viewed as a 
secondary finding. Other manifestations are: 
headache, vertigo, movement disorders, paresis, 
and stroke such as events, cognitive impairment, 
psychiatric disorders, pyramidal signals, and 
seizures.2 When regions other than globus pallidus 
are involved pathological calcifications occur.3 
Calcification may occur secondary to 
abnormalities in calcium metabolism or radiation 
therapy.4 Bilateral calcification of basal ganglia can 
be found both on plain skull X-rays (SXR), in  
70-80% of cases associated with 
hypoparathyroidism, and in necropsy specimens.5 
The syndrome has a sporadic idiopathic form and 
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a familial form, which is associated with 
progressive mental deterioration and growth 
retardation chorea, dementia, and dystonia.6 
Another finding is levodopa-resistant Parkinson 
syndrome.7 Computerized tomography (CT) 
make it possible to detect calcifications which 
otherwise are not noticeable on SXR.5 For 
instance, normal SXR was reported in 14 cases of 
basal ganglia calcification, without any evidence 
of calcium abnormalities, or neurological disease 
due to calcification.7 Furthermore, several reports 
have described familial Fahr’s syndrome.6 Some 
literatures have described idiopathic familial 
basal ganglia calcification without clinical 
manifestations.1 An array of clinical 
manifestations in familial Fahr’s syndrome may 
be presented depending on age, level of calcium 
deposits in the brain, and due neurological 
deficit.1 In general, progressive neurological 
deterioration may results in disability and death.8 
No cure or typical treatment has yet been 
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recognized for Fahr’s syndrome and treatment of 
individual cases have shown that haloperidol or 
lithium carbonate may relieve psychotic 
symptoms.8 
Case Report 
A 38-year-old woman referred to the psychiatric 
clinic of 5th Azar Hospital, Gorgan, Iran, in April 
2011 due to headache, anemia, feeling of 
isolation, self-talk, and excessive movements of 
the upper limbs. She was hospitalized for further 
investigation in the psychiatric ward due to the 
severity of symptoms. Eight months before 
admission the patient was hospitalized and 
treated with the electric shock therapy because of 
symptoms such as depression, suicide attempt, 
loss of energy and insomnia, and diagnosis of 
psychotic depression. Then she was discharged 
after improvement of symptoms with 
perphenazin prescription and amitriptyline. 
There was no major problem until about 20 days 
before the current admission which after 
discontinuing the medication he had insomnia, 
headache, and self-talk. The patient complained 
of continuous non-pulsatile headache in the 
occipital region without nausea and vomiting. 
Except one of the patient’s brothers who had 
familial Mediterranean fever, other family 
members had no history of psychiatric diseases. 
The patient had severe reduction of intellectual 
content and auditory hallucinations, cognitive 
impairment in attention, and concentration. The 
brain CT scan without contrast injection showed 
bilateral calcifications in the basal ganglia and left 
cerebellar (Figure 1). Electrocardiography, 
calcium, phosphorus, alkaline phosphatase, and 
albumin were within normal ranges. 
Ophthalmology consultation was normal. 
Radiographs obtained from the patients’ hands 
showed no other calcium disorders. According to 
the above findings, Fahr’s induced psychotic 
syndrome was revealed, and treatment began with 
perphenazin 16 mg/day about 3 weeks later, pain 
and auditory hallucinations disappeared 
completely and patient’s cognitive weakness 
improved. Six months later, patient was on 
maintenance treatment with no psychotic features. 
 
 
Figure 1. Computerized tomography scan of 
Fahr’s syndrome showing bilateral basal 
ganglia calcification in a 38-year-old woman 
Discussion 
Although the etiology of calcification of the 
basal ganglia is rarely defined, abnormalities in 
vascular supply, calcium metabolism, and 
alkaline phosphatase activity appear to be 
involved. Clinical expression of Fahr’s disease 
(FD) can vary greatly.2 Patients with basal 
ganglia calcification may present initially with 
psychiatric features.9 In our case, there was no 
evidence of hypocalcaemia and 
hyperphosphatemia in the patient. There was no 
evidence of extrapyramidal symptoms or a 
metabolic disorder and neurological 
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examination was normal. However, psychosis 
can induce differential diagnosis of 
schizophrenia or acute transient psychotic 
disorder.2 Psychiatric presentations including 
cognitive, psychosis, and mood disorders are 
common in FD.9 Other studies indicate the 
presence of symptoms such as auditory 
hallucinations, perceptual distortions, and 
paranoid delusions associated with FD.9 As in 
our case schizophreniform psychoses have been 
reported. Psychosis due to FD responds variably 
to treatment and is sometimes unresponsive.8 
Imaging diagnosis could be the starting point to 
guide the clinician for the possibility of Fahr’s 
syndrome.1,5 The differential diagnosis includes 
but not limited to: Parkinson’s disease, 
Huntington’s disease, progressive supranuclear 
palsy, Wilson’s disease, spasmodic torticollis, 
oligodendroglioma, low-grade astrocytoma, and 
arteriovenous malformation.6 Etiology of Fahr’s 
syndrome is not directly correlated with image 
calcification pattern, except for some differences 
noticed in calcifications site in dystrophic senile 
ones. Topographic image studies are promising 
to predict neurological deficits. Their recognition 
by CT is easy, has maximum sensitivity and may 
be contributing to early treatment.1 
Conclusion 
Our case shows that schizophreniform 
symptomatology presentations must be 
investigated in detail with due importance to 
family history and considering disorders with 
other clinical manifestations like FD. 
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